Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Advances in optical and pharmacological strategies for myopia correction in children

In conclusion, while several interventions show potential, further long-term studies and personalized treatment strategies are needed to optimize outcomes.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review of optical and pharmacological myopia treatments in children reports that low-dose atropine (0.01%) was the most effective option in its comparison, with minimal side effects. The authors state that pirenzepine, apomorphine and 7-methylxanthine need further validation, and that low-level red-light therapy and DOT lenses show promise but their long-term safety and mechanisms remain unclear.

Who or what was studied
Children with myopia
Limits stated in the abstract
The abstract states that long-term safety and efficacy of several interventions remain under investigation and that some agents have only been tested in animal models or need broader clinical testing.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on e-century.us.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Myopia, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies